- Conditions
- Pancreas Adenocarcinoma (MSI-H), Pancreatic Neuroendocrine Tumors (pNET)
- Locations
-
- Hôpital Privé Jean Mermoz Lyon, France
Clinical trial condition
Pancreatic Neuroendocrine Tumors (pNET)
Explore clinical trials studying Pancreatic Neuroendocrine Tumors (pNET). Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Pancreatic Neuroendocrine Tumors (pNET) trial results
NCT07536087
- Conditions
- Endoscopic Ultrasound-Guided Radiofrequency Ablation, Neoplasms, Neoplasms by Histologic Type, +6 more
- Locations
-
- Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology Prague, Czechia
Not yet recruiting
Adjuvant Trial in Pancreatic Neuroendocrine Tumors
NCT07591493
- Conditions
- Pancreatic Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors (pNET)
- Locations
-
- Gustave Roussy Villejuif, Île-de-France Region, France
Enrolling by invitation
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
NCT07620574
- Conditions
- Adenocarcinoma, Cancer, Carcinoma, +39 more
- Locations
-
- New York Cancer and Blood Specialists Bay Shore, New York, United States
- Greater Dayton Cancer Center Kettering, Ohio, United States
NCT01658436
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
- Locations
-
- Indiana University SC Indianapolis, Indiana, United States
- Dana Farber Cancer Institute GastrointestionalCancer Clinic Boston, Massachusetts, United States
- Montefiore Medical Center SC-2 The Bronx, New York, United States
- Ohio State Comprehensive Cancer Center/James Cancer Hospital SC Columbus, Ohio, United States